Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Abstract No. 567 Yttrium-90 radioembolization therapy for combined hepatocellular and cholangiocarcinoma

Journal of Vascular and Interventional Radiology(2020)10.1016/j.jvir.2019.12.628Source: DataRank Database

Abstract No. 567 Yttrium-90 radioembolization therapy for combined hepatocellular and cholangiocarcinoma is a research paper published in Journal of Vascular and Interventional Radiology (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: bronzeTopics (11)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

W. Badar,A. Salaskar,S. Zangan,R. Navuluri,T. Baker

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W3007985759

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttp://www.jvir.org/article/S1051044319316926/pdf

publisherhttp://www.jvir.org/article/S1051044319316926/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1051044319316926?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1051044319316926?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jvir.2019.12.628

Fields of Study

Cholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and Prognosis

Keywords

MedicineCommon Terminology Criteria for Adverse EventsAdverse effectResponse Evaluation Criteria in Solid TumorsHepatocellular carcinomaInternal medicineSurgeryToxicityPhases of clinical research

Sustainable Development Goals

SDG 0: Good health and well-being